Molecular Detection raises $1.4M for disease diagnostics
Molecular Detection Inc. has raised $1.4 million in equity to develop a series of tests for infectious diseases, according to a regulatory filing. with the Securities and Exchange Commission. The company says its Detect-Ready technology offers a more quick and accurate means of diagnosing diseases. Its first product tests nasal samples for MRSA, a staph […]